Newsletters
![Sidebar Image](https://cdnmedia.eurofins.com/corporate-eurofins/media/314417/capture.png)
Bio/Pharmaceutical NEWS - Fall 2022
Eurofins BioPharma Product Testing network of laboratories publishes a newsletter two times per year, presenting new services and analytical techniques, research projects, major events and other topics related to bio/pharma product testing.
Technical Articles
- Bridging the gaps from small molecule testing to support next-generation biologics
- EBPT San Diego offers cell based bioassays in collaboration with other US sites
- Detection of mycobacterium species in qPCR as a consideration for cell banking testing to support cell and gene therapy manufacturing
- New Raw Materials Cell Based Services target cell viability and cell potency assays
- BioFire® assay blazes path to delivering mycoplasma results within three days or less
- Micro’s new Bruker MALDI speeds organism identification with database of 10,000 bacteria and yeast organism entries
General Information Articles
- From Online Ordering to LAWS server-to-server integration, Eurofins BPT offers faster, more secure data delivery
- Eurofins BioPharma Product Testing ENCO expands US capabilities footprint
- Understanding the when, why, and how - Eurofins Human Factors MD helps clients develop safe and effective therapies, one human factors study at a time
- People Are our Chemistry: Scott Kingsley
Previous Bio/Pharmaceutical NEWS issues
To view newsletters prior to 2019, click here.
Eurofins BioPharma News
Eurofins network of companies also publishes a newsletter three times per year, presenting new services and analytical techniques, research projects, major events and other related topics for the broader bio/pharma industry, including Discovery, Pre-Clinical/Early Development, Genomics, Clinical, Specialty Clinical Diagnostics, BioPharma Product Testing and Contract Development & Manufacturing.
Click here to view all past issues of Eurofins BioPharma News